Shares of Elite Pharmaceuticals, Inc. ELTP have lost 15.7% since the company reported its earnings for the fiscal year ended March 31, 2025. This compares to the S&P 500 Index’s 0.9% gain over ...

CSCO, CAT and SCHW shares outperformed peers as analysts highlight growth drivers and risks in key business segments.